These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 761338)

  • 1. Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
    Thadani U; Parker JO
    Circulation; 1979 Mar; 59(3):571-9. PubMed ID: 761338
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol in angina pectoris: comparison of therapy given two and four times daily.
    Thadani U; Parker JO
    Am J Cardiol; 1980 Jul; 46(1):117-23. PubMed ID: 7386384
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
    Thadani U; Parker JO
    Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in patients with angina pectoris.
    Gianelly RE; Goldman RH; Treister B; Harrison DC
    Ann Intern Med; 1967 Dec; 67(6):1216-25. PubMed ID: 4964853
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Moran JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4988122
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy of angina pectoris with propranolol and long-acting nitrates.
    Goldbarg AN; Morgan JF; Butterfield TK; Nemickas R; Bermudez GA
    Circulation; 1969 Dec; 40(6):847-53. PubMed ID: 4990005
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris.
    Bassan MM; Weiler-Ravell D
    Am Heart J; 1983 Feb; 105(2):234-8. PubMed ID: 6823805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose-effect relationship and duration of the effect of diltiazem in stable effort angina. Comparison with propranolol].
    Lagioia R; Mangini SG; Dibenedetto A; Scrutinio D; Rizzon P
    Cardiologia; 1985 Mar; 30(3):213-21. PubMed ID: 4064072
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of angina pectoris with propranolol: the harmful effects of cigarette smoking.
    Deanfield J; Jonathan A; Selwyn A; Fox KM
    Cardiology; 1981; 68 Suppl 2():186-9. PubMed ID: 7317896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prophylactic value of propranolol in angina pectoris.
    Rabkin R; Stables DP; Levin NW; Suzman MM
    Am J Cardiol; 1966 Sep; 18(3):370-83. PubMed ID: 4958813
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
    Thadani U; Fung HL; Darke AC; Parker JO
    Circulation; 1980 Sep; 62(3):491-502. PubMed ID: 7398008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of patients with stable angina by combination of trinitrolong and propranolol].
    Kukushkin SK; Metelitsa VI; Kokurina EV; Bochkarëva EV
    Klin Med (Mosk); 1993; 71(5):30-3. PubMed ID: 8301980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.
    Halkin H; Vered I; Saginer A; Rabinowitz B
    Eur J Clin Pharmacol; 1979; 16(6):387-91. PubMed ID: 393520
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.
    Pine M; Favrot L; Smith S; McDonald K; Chidsey CA
    Circulation; 1975 Nov; 52(5):886-93. PubMed ID: 1175271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
    Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 19. Propranolol and isosorbide dinitrate synergism in angina pectoris.
    Russek HI
    Am J Cardiol; 1968 Jan; 21(1):44-54. PubMed ID: 5634742
    [No Abstract]   [Full Text] [Related]  

  • 20. The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect.
    Bassan M; Weiler-Ravell D; Shalev O
    Circulation; 1982 Oct; 66(4):710-6. PubMed ID: 7116588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.